Posted in | News

Delphi Completes $2.8 Billion Refinancing Plan

Delphi has announced the completion of its $2.8 billion refinancing plan, comprised of a $1.8 billion secured revolving credit facility and a $1.0 billion secured term loan. Delphi believes the completion of this refinancing plan provides the company with access to sufficient liquidity to continue to address its U.S. legacy cost issues during the current low GM North American production environment.

"We are extremely pleased with this successful refinancing and the high level of support from our lead banks, JP Morgan and Citigroup, and our other lenders and investors. We achieved what we set out to accomplish in securing a financing deal that will provide us the liquidity and flexibility to continue our transformation," said John D Sheehan, Delphi's acting chief financial officer. "Additionally, we made a second contribution of $475 million to fund our U.S. pension plans, bringing our total contributions this quarter to $625 million and fulfilling our minimum 2005 pension contribution requirements.”

The term loan is due in full on June 14, 2011, while the revolving credit facility is available to the company through June 18, 2009. Upon completion of the refinancing, Delphi terminated its 364-day revolving credit line of $1.5 billion, which was due to expire on June 17, 2005. There were no outstanding borrowings under that facility.

http://www.delphi.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.